Anbio Biotechnology: cashflow_investing

Value{"amount": 337101, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2024-01-01 – 2024-12-31
Statuscurrent
EntityAnbio Biotechnology
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-25-035802
Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001982708/cashflow-investing/2024-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/f903b492-2310-45d3-8f51-af6616225c1d

History